Comphya and Komp-ACT win the second stage of Venture Kick
15.09.2017
The two startup projects and their teams win CHF 20’000 each. They are now getting ready for the big final where they might win CHF 130’000 in total.
 Comphya CTO Rodrigo Araujo Fraga de Silva
|
 |
 The team of Komp-ACT
|
|
Comphya (EPFL) – Life Science: Comphya develops an active implantable medical device to restore the erectile function of patients who are non-responsive to oral drugs (e.g. Viagra or Cialis). To achieve erection, these patients have access to problematic and outdated methods such as intrapenile injections of vasodilators or penile implants. Comphya fills the need for better modalities for these patients, with a main focus on spinal cord injury and prostatectomy patients, both large segments with high potential of use.
Komp-ACT (EPFL) - Aerospace: Komp-ACT aims to develop breakthrough electric motors for aircrafts, helicopters and UAVs actuation systems as well as for electric aircrafts propulsion systems. Their lightweight and smart electric motors can reduce aircrafts weight, maintenance costs, prevent electric and mechanical failures as well as reduce fuel consumption and CO2 emissions.
Komp-ACT (EPFL) - Aerospace: Komp-ACT aims to develop breakthrough electric motors for aircrafts, helicopters and UAVs actuation systems as well as for electric aircrafts propulsion systems. Their lightweight and smart electric motors can reduce aircrafts weight, maintenance costs, prevent electric and mechanical failures as well as reduce fuel consumption and CO2 emissions.